Leukoderma is the clinical term for “white skin,” referring to light or white patches that appear when the skin loses its natural pigment. In Milady cosmetology and esthetics textbooks, it’s categorized as a pigmentation disorder that skincare professionals need to recognize when working with clients. Understanding what causes these patches and how they differ from other pigment conditions helps you identify them during skin analysis and adjust treatments accordingly.
How Leukoderma Develops
Skin gets its color from melanin, a pigment produced by specialized cells called melanocytes. In leukoderma, those melanocytes become damaged or destroyed in certain areas, so they stop producing melanin. The result is localized white or lighter patches that contrast with the surrounding skin. These patches can appear in a small area, multiple spots, or occasionally across larger regions of the body.
The damage to melanocytes can happen through several pathways. One well-studied mechanism involves certain chemical compounds that have a structure similar to the raw materials melanocytes normally use to build pigment. When these compounds enter the melanocyte, they get processed by the same enzyme (tyrosinase) that drives pigment production. Instead of creating melanin, though, the reaction produces harmful molecules called reactive oxygen species that damage the cell from the inside out. This is why certain chemicals found in cosmetics, cleaning products, and industrial materials can trigger leukoderma in people who are exposed to them.
Leukoderma vs. Vitiligo vs. Albinism
These three conditions all involve pigment loss, but they differ in important ways. Milady textbooks distinguish between them, and the differences matter for esthetic practice.
Leukoderma is generally an acquired condition, meaning it develops after birth in response to some trigger: chemical exposure, burns, skin inflammation, or other injury. It often appears in a limited area. Albinism, by contrast, is a genetic condition present from birth that affects pigment production across the entire body, including the hair and eyes.
The relationship between leukoderma and vitiligo is more nuanced. Leukoderma is a broad descriptive term for any white patches caused by pigment loss, while vitiligo is a specific autoimmune condition where the body’s immune system attacks its own melanocytes. In clinical use, when chemical exposure causes temporary, localized pigment loss that resolves once the chemical is removed, it’s called chemical leukoderma. But when the depigmentation doesn’t recover after the chemical is gone, or new white patches appear in areas that were never exposed, it’s reclassified as chemical-induced vitiligo. This distinction matters because it signals that the melanocytes have been permanently destroyed, often through autoimmune activity or depletion of the stem cells that would normally replace them.
Common Causes and Triggers
Leukoderma can result from a range of triggers, which is why Milady coursework emphasizes recognizing it during client consultations. The most common causes include:
- Chemical exposure: Certain phenol-based compounds found in hair dyes, adhesives, rubber products, and some skincare ingredients can be toxic to melanocytes. People who work with industrial chemicals or use products containing these compounds on their skin are at higher risk.
- Burns and trauma: Thermal burns, friction injuries, or severe inflammation can destroy melanocytes in the affected area, leaving behind lighter patches as the skin heals.
- Post-inflammatory changes: After conditions like eczema, psoriasis, or certain infections clear up, the skin may temporarily or permanently lose pigment in the areas that were inflamed.
- Autoimmune response: In some cases, what begins as localized pigment loss progresses into a broader autoimmune pattern where the body continues attacking melanocytes beyond the original site of injury.
What It Looks Like on Clients
Leukoderma presents as flat, white or noticeably lighter patches on the skin. The patches have no texture change: the skin isn’t raised, scaly, or rough. They’re most visible on darker skin tones, where the contrast between affected and unaffected areas is pronounced. On lighter skin, the patches may only become obvious after sun exposure, when the surrounding skin tans but the depigmented areas do not.
The patches can appear anywhere on the body. In chemical leukoderma, they typically show up at the site of contact with the triggering substance, often the hands, wrists, or face. In autoimmune-related cases, they tend to appear symmetrically on both sides of the body.
Why It Matters for Esthetic Practice
Milady training covers leukoderma because estheticians need to handle affected skin carefully. Depigmented patches lack the natural UV protection that melanin provides, making those areas significantly more vulnerable to sun damage. Any facial or body treatment that increases UV sensitivity, such as chemical peels or exfoliating acids, requires extra caution.
Laser treatments carry specific risks for clients with pigment disorders. There is documented evidence of vitiligo being triggered or worsened by laser hair removal, along with other inflammatory reactions in the treated area. This doesn’t mean all laser services are off-limits, but it does mean a thorough intake process matters. Estheticians should note any areas of pigment loss during the skin analysis and factor them into treatment planning.
Products containing hydroquinone or other lightening agents should not be applied to already depigmented areas, as they could worsen the contrast or further suppress melanocyte function. Sun protection is critical for affected clients: broad-spectrum SPF on exposed patches helps prevent burns and reduces the visible contrast between pigmented and unpigmented skin. For clients who are self-conscious about the appearance of their patches, cosmetic camouflage products designed for vitiligo and leukoderma can provide effective, temporary coverage that blends with surrounding skin tones.